- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Growth Potential Companies
U.S. Pharmaceuticals & Biotech High Growth Potential Companies
Results
170
2 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
170 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AXSM | US$127.08 | 18.3% | 30.2% | US$5.1b | US$145.13 | PS18.2x | E58.5% | n/a | ||
TVTX | US$21.10 | 4.4% | 138.1% | US$1.9b | US$28.47 | PS9x | E61.9% | n/a | ||
ZVRA | US$7.53 | -1.6% | 23.2% | US$414.7m | US$20.75 | PS16.4x | E57.2% | n/a | ||
RCEL | US$8.80 | -0.8% | -49.7% | US$229.4m | US$17.08 | PS3.9x | E51.9% | n/a | ||
TGTX | US$32.25 | 2.4% | 112.5% | US$4.7b | US$40.33 | PS17.5x | E43.6% | n/a | ||
ALNY | US$274.06 | 1.1% | 69.2% | US$35.3b | US$299.74 | PS16.9x | E56.7% | n/a | ||
HRMY | US$37.99 | -1.8% | 9.9% | US$2.1b | US$54.13 | PE17.7x | E31.5% | n/a | ||
ITCI | US$127.12 | -0.06% | 74.8% | US$13.5b | US$132.73 | PS22x | E52.9% | n/a | ||
ARDX | US$5.57 | 5.3% | -42.8% | US$1.3b | US$10.19 | PS5.2x | E55.3% | n/a | ||
CLNN | US$4.55 | -0.4% | -45.8% | US$34.8m | US$45.17 | PS86.2x | E59.1% | n/a | ||
BPMC | US$104.00 | -6.7% | 34.1% | US$6.7b | US$126.05 | PS15.2x | E55.7% | n/a | ||
AVDL | US$9.09 | 14.1% | n/a | US$781.5m | US$18.22 | PS6.3x | E55.2% | n/a | ||
RNXT | US$1.15 | -16.1% | -25.3% | US$27.9m | US$5.50 | PB3.9x | E63.5% | n/a | ||
ABEO | US$5.82 | 5.8% | -10.2% | US$247.8m | US$15.90 | PB5.5x | E57.8% | n/a | ||
ENSC | US$5.80 | -12.1% | -66.1% | US$8.0m | US$52.25 | PS1.7x | E102.6% | n/a | ||
ASND | US$119.49 | -4.5% | -17.4% | US$7.2b | US$193.27 | PS21.2x | E57.7% | n/a | ||
ALDX | US$5.99 | 15.9% | 76.7% | US$353.1m | US$10.00 | PB4.2x | E60.0% | n/a | ||
CKPT | US$3.23 | 1.9% | 62.3% | US$160.7m | US$12.00 | PS3355.9x | E46.1% | n/a | ||
MDGL | US$337.56 | 3.7% | 56.0% | US$7.3b | US$379.43 | PS95.8x | E59.9% | n/a | ||
SWTX | US$54.00 | 50.8% | 17.6% | US$3.0b | US$67.50 | PS29.6x | E67.8% | n/a | ||
EVOK | US$4.84 | 1.3% | -41.6% | US$9.9m | US$18.00 | PS1.2x | E124.7% | n/a | ||
SPRY | US$11.74 | -4.6% | 57.4% | US$1.2b | US$29.80 | PS444.3x | E62.4% | n/a | ||
TNYA | US$0.90 | -14.6% | -84.2% | US$76.4m | US$18.50 | PB0.6x | E57.8% | n/a | ||
NTRB | US$7.15 | -2.9% | 176.1% | US$86.7m | US$13.00 | PS39.3x | E94.3% | n/a |